Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

01.04.2024

2 Acta Neuropathol
4 Alzheimers Dement
1 Ann Neurol
1 BMC Geriatr
1 Brain
3 Brain Res
3 Curr Alzheimer Res
1 Exp Gerontol
1 Geriatrics (Basel)
15 J Alzheimers Dis
2 J Am Geriatr Soc
1 J Neurochem
3 J Neurol
2 Nat Neurosci
1 Nature
3 Neurobiol Dis
3 Neurology
2 PLoS One



    Acta Neuropathol

  1. MALDONADO-DIAZ C, Hiya S, Yokoda RT, Farrell K, et al
    Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.
    Acta Neuropathol. 2024;147:58.
    >> Share

  2. BOUTER Y, Noguerola JSL, Tucholla P, Crespi GAN, et al
    Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models.
    Acta Neuropathol. 2024;147:59.
    >> Share


    Alzheimers Dement

  3. SINTINI I, Singh NA, Li D, Mielke MM, et al
    Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 25. doi: 10.1002/alz.13713.
    >> Share

  4. VAN VELUW SJ, Young MJ
    Ethical considerations for the use of anti-amyloid immunotherapy in patients with early Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 25. doi: 10.1002/alz.13795.
    >> Share

  5. RAHIMZADEH N, Srinivasan SS, Zhang J, Swarup V, et al
    Gene networks and systems biology in Alzheimer's disease: Insights from multi-omics approaches.
    Alzheimers Dement. 2024 Mar 27. doi: 10.1002/alz.13790.
    >> Share

  6. DAKTERZADA F, Jove M, Cantero JL, Mota-Martorell N, et al
    The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 27. doi: 10.1002/alz.13792.
    >> Share


    Ann Neurol


  7. Retraction: 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of alzheimer disease.
    Ann Neurol. 2024 Mar 28. doi: 10.1002/ana.26938.
    >> Share


    BMC Geriatr

  8. LEONG CA, Summers A, Grote V, Jackson K, et al
    Randomized controlled trial of a positive emotion regulation intervention to reduce stress in family caregivers of individuals with Alzheimer's disease: protocol and design for the LEAF 2.0 study.
    BMC Geriatr. 2024;24:289.
    >> Share


    Brain

  9. HUNG C, Fertan E, Livesey FJ, Klenerman D, et al
    APP antisense oligonucleotides reduce Abeta aggregation and rescue endolysosomal dysfunction in Alzheimer's disease.
    Brain. 2024 Mar 25:awae092. doi: 10.1093.
    >> Share


    Brain Res

  10. GENG C, Tan L, Chenchen
    Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
    Brain Res. 2024 Mar 20:148881. doi: 10.1016/j.brainres.2024.148881.
    >> Share

  11. BEIYU Z, Rong Z, Yi Z, Shan W, et al
    Oxidative stress is associated with Abeta accumulation in chronic sleep deprivation model.
    Brain Res. 2024;1829:148776.
    >> Share

  12. CLELAND NRW, Potter GJ, Buck C, Quang D, et al
    Altered metabolism and DAM-signatures in female brains and microglia with aging.
    Brain Res. 2024;1829:148772.
    >> Share


    Curr Alzheimer Res

  13. GAJOWNICZEK-ALASA D, Szwajgier D, Baranowska-Wojcik E
    Plant Soup Formulations Show Cholinesterase Inhibition Potential in the Prevention of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Mar 22. doi: 10.2174/0115672050306101240321050146.
    >> Share

  14. NAGORI K, Pradhan M, Sharma M, Ajazuddin, et al
    Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Mar 25. doi: 10.2174/0115672050306008240321034006.
    >> Share

  15. YU B, Wan G, Cheng S, Wen P, et al
    Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study.
    Curr Alzheimer Res. 2024 Mar 25. doi: 10.2174/0115672050303878240319054149.
    >> Share


    Exp Gerontol

  16. UKRAINTSEVA S, Yashkin AP, Akushevich I, Arbeev K, et al
    Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in AD.
    Exp Gerontol. 2024 Mar 26:112411. doi: 10.1016/j.exger.2024.112411.
    >> Share


    Geriatrics (Basel)

  17. MCGEE JS, Polson EC, Myers DR, McClellan A, et al
    Hope Mediates Stress to Reduce Burden in Family Caregivers of Persons with Alzheimer's Disease.
    Geriatrics (Basel). 2024;9:38.
    >> Share


    J Alzheimers Dis

  18. MATTKE S, Jun H, Chu S, Hanson M, et al
    Disparities in Access to Diagnostic Evaluation for Alzheimer's Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study.
    J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231134.
    >> Share

  19. ZHANG M, Qu Y, Li Q, Gu C, et al
    Correlation Between Prefrontal Functional Connectivity and the Degree of Cognitive Impairment in Alzheimer's Disease: A Functional Near-Infrared Spectroscopy Study.
    J Alzheimers Dis. 2024 Mar 21. doi: 10.3233/JAD-230648.
    >> Share

  20. BALLENGER J, George DR, Whitehouse PJ
    Digging Deeper: What Can We Really Learn about Dementia from History?
    J Alzheimers Dis. 2024;98:417-419.
    >> Share

  21. ORR ME
    A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain.
    J Alzheimers Dis. 2024;98:411-415.
    >> Share

  22. SHIMADA H, Doi T, Tsutsumimoto K, Makino K, et al
    Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.
    J Alzheimers Dis. 2024;98:659-669.
    >> Share

  23. ZHANG XX, Wang HR, Meng-Wei, Hu YZ, et al
    Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.
    J Alzheimers Dis. 2024;98:373-385.
    >> Share

  24. WANG J, Leong IT, Johnson MK, Pei Y, et al
    What Matters to Chinese and Korean American Dementia Caregivers: Navigating Cultural Influences in Dementia Care from Caregivers' Perspectives.
    J Alzheimers Dis. 2024;98:519-538.
    >> Share

  25. VERA R, Hong N, Jiang B, Liang G, et al
    Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
    J Alzheimers Dis. 2024;98:549-562.
    >> Share

  26. GREENBLATT CL, Lathe R
    Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.
    J Alzheimers Dis. 2024;98:361-372.
    >> Share

  27. WANG Y, Wang S, Wu J, Liu X, et al
    Causal Association Between Allergic Diseases and Dementia: Evidence from Multivariate Mendelian Randomization Study.
    J Alzheimers Dis. 2024;98:505-517.
    >> Share

  28. PARKER DC, Whitson HE, Smith PJ, Kraus VB, et al
    Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-beta Accumulation.
    J Alzheimers Dis. 2024;98:593-600.
    >> Share

  29. SHUI L, Shibata D, Chan KCG, Zhang W, et al
    Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization.
    J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-231149.
    >> Share

  30. LI Y, Xu X, Wang P, Chen X, et al
    Association of Cancer History with Lifetime Risk of Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231223.
    >> Share

  31. POLIS B, Samson AO
    Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.
    J Alzheimers Dis. 2024 Mar 19. doi: 10.3233/JAD-240058.
    >> Share

  32. CUMMINGS J
    "Landscape of Phase 2 Trials in Alzheimer's Disease": Perspective on Adaptive Trials.
    J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-240145.
    >> Share


    J Am Geriatr Soc

  33. BURKE LG, Burke RC, Duggan CE, Figueroa JF, et al
    Trends in observation stays for Medicare beneficiaries with and without Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2024 Mar 28. doi: 10.1111/jgs.18890.
    >> Share

  34. YANG MT, Temkin-Greener H, Veazie P, Cai S, et al
    Post-acute care transitions during COVID-19: Racial, ethnic, and socioeconomic differences in older adults with Alzheimer's disease and related dementia.
    J Am Geriatr Soc. 2024 Mar 27. doi: 10.1111/jgs.18884.
    >> Share


    J Neurochem

  35. NETZAHUALCOYOTZI C, Santillan-Cigales JJ, Adalid-Peralta LV, Velasco I, et al
    Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases.
    J Neurochem. 2024 Mar 29. doi: 10.1111/jnc.16106.
    >> Share


    J Neurol

  36. MENDES AJ, Ribaldi F, Lathuiliere A, Ashton NJ, et al
    Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort.
    J Neurol. 2024;271:2053-2066.
    >> Share

  37. O'CONNOR A, Lyons S, Finnegan M, Walsh J, et al
    Expanding the phenotype of psychiatric-onset prodromal dementia with Lewy bodies.
    J Neurol. 2024;271:2125-2128.
    >> Share

  38. SARTO J, Esteller-Gauxax D, Tort-Merino A, Guillen N, et al
    Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort.
    J Neurol. 2024;271:1973-1984.
    >> Share


    Nat Neurosci

  39. WILSON EN, Wang C, Swarovski MS, Zera KA, et al
    TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models.
    Nat Neurosci. 2024 Mar 27. doi: 10.1038/s41593-024-01610.
    >> Share

  40. MANCUSO R, Fattorelli N, Martinez-Muriana A, Davis E, et al
    Xenografted human microglia display diverse transcriptomic states in response to Alzheimer's disease-related amyloid-beta pathology.
    Nat Neurosci. 2024 Mar 27. doi: 10.1038/s41593-024-01600.
    >> Share


    Nature


  41. A test for Alzheimer's-disease stage predicts dementia risk.
    Nature. 2024;628:11.
    >> Share


    Neurobiol Dis

  42. JADHAV VS, Stair JG, Eck RJ, Smukowski SN, et al
    Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets.
    Neurobiol Dis. 2024;193:106441.
    >> Share

  43. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    >> Share

  44. SCHRAEN-MASCHKE S, Duhamel A, Vidal JS, Ramdane N, et al
    The free plasma amyloid Abeta(1)(-)(42)/Abeta(1)(-)(40) ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Abeta(1)(-)(42)/Abeta(1)(-)(40) ratio. The BALTAZAR study.
    Neurobiol Dis. 2024;193:106459.
    >> Share


    Neurology

  45. BUCKLEY RF, Schindler SE
    Lower Accuracy Alzheimer Disease Blood Tests Will Never Be "Ready for Prime Time".
    Neurology. 2024;102:e209295.
    >> Share

  46. TARAWNEH R
    YKL-40 as a New Plasma Biomarker for Dementia Risk: Are We There Yet?
    Neurology. 2024;102:e209145.
    >> Share

  47. BOUTELOUP V, Pellegrin I, Dubois B, Chene G, et al
    Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia.
    Neurology. 2024;102:e209219.
    >> Share


    PLoS One

  48. AHMADI M, Javaheri D, Khajavi M, Danesh K, et al
    A deeply supervised adaptable neural network for diagnosis and classification of Alzheimer's severity using multitask feature extraction.
    PLoS One. 2024;19:e0297996.
    >> Share

  49. ROYALL DR, Palmer RF
    INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach.
    PLoS One. 2024;19:e0295386.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016